Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Accounts Payables (2011 - 2026)

Lite Strategy (LITS) posted Accounts Payables of $253000.0 for Q1 2026, down 22.63% on a QoQ basis from $327000.0 in Q4 2025, and up 42.94% year-over-year from $177000.0 in Q1 2025.

Analysis

Lite Strategy (LITS) Accounts Payables (2011 - 2026) Analysis & Trends

Lite Strategy has reported Accounts Payables for 16 years, with the latest figure at $253000.0 in Q1 2026.

  • On a quarterly basis, Accounts Payables rose 42.94% year-over-year to $253000.0 in Q1 2026; TTM through Mar 2026 was $253000.0, a 42.94% increase from a year earlier, with the FY2025 full-year figure at $176000.0, down 94.44% from the prior year.
  • Accounts Payables was $253000.0 for Q1 2026 at Lite Strategy, down from $327000.0 in the prior quarter.
  • The five-year high for Accounts Payables was $8.4 million in Q3 2022, with the low at $176000.0 in Q2 2025.
  • Average Accounts Payables over 5 years is $3.1 million, with a median of $3.2 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Accounts Payables soared 48.21% in 2022, then tumbled 94.44% in 2025.
  • Over 5 years, Accounts Payables stood at $4.1 million in 2022, then plunged by 66.12% to $1.4 million in 2023, then slumped by 56.75% to $596000.0 in 2024, then tumbled by 45.13% to $327000.0 in 2025, then fell by 22.63% to $253000.0 in 2026.
  • The last three Accounts Payables figures came in at $253000.0 (Q1 2026), $327000.0 (Q4 2025), and $503000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 25.08 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - 253,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 253,000.00
Dec 31, 2025 327,000.00
Sep 30, 2025 503,000.00
Jun 30, 2025 176,000.00
Mar 31, 2025 177,000.00
Dec 31, 2024 596,000.00
Sep 30, 2024 976,000.00
Jun 30, 2024 3.17 Mn
Mar 31, 2024 3.18 Mn
Dec 31, 2023 1.38 Mn
Sep 30, 2023 3.22 Mn
Jun 30, 2023 6.13 Mn
Mar 31, 2023 4.39 Mn
Dec 31, 2022 4.07 Mn
Sep 30, 2022 8.42 Mn
Jun 30, 2022 7.92 Mn
Mar 31, 2022 8.26 Mn
Dec 31, 2021 6.26 Mn
Sep 30, 2021 8.47 Mn
Jun 30, 2021 6.36 Mn